BCLI
Goldman Sachs’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-17,600
| Closed | -$58K | – | 5534 |
|
|
2021
Q3 | $58K | Sell |
17,600
-40,079
| -69% | -$132K | ﹤0.01% | 5155 |
|
|
2021
Q2 | $220K | Buy |
57,679
+34,075
| +144% | +$130K | ﹤0.01% | 4869 |
|
|
2021
Q1 | $90K | Sell |
23,604
-7,203
| -23% | -$27.5K | ﹤0.01% | 5055 |
|
|
2020
Q4 | $139K | Buy |
+30,807
| New | +$139K | ﹤0.01% | 4393 |
|
|
2020
Q3 | – | Sell |
-17,820
| Closed | -$200K | – | 4422 |
|
|
2020
Q2 | $200K | Sell |
17,820
-10,058
| -36% | -$113K | ﹤0.01% | 3986 |
|
|
2020
Q1 | $129K | Buy |
+27,878
| New | +$129K | ﹤0.01% | 4107 |
|
|
2018
Q3 | – | Sell |
-13,820
| Closed | -$54K | – | 4111 |
|
|
2018
Q2 | $54K | Buy |
+13,820
| New | +$54K | ﹤0.01% | 4056 |
|